News & Updates

In patients with left-sided malignant colorectal obstruction (LMCO), deferring surgery for >4 weeks after placement of self-expanding metallic stent (SEMS) appears to yield better short-term clinical outcomes, according to a recent study.

Fruquintinib, a highly selective and potent oral tyrosine kinase inhibitor of VEGFR*-1, -2, and -3, significantly improves overall survival (OS) in heavily pretreated patients with metastatic colorectal cancer (mCRC), according to the FRESCO-2** trial presented at ESMO 2022.

Currently in vogue, intermittent fasting (IF) – which switches between periods of eating and fasting – may not be as beneficial as many have thought.

COVID-19 reinfection doubles the risk of death and triples the risk of hospitalization, with post-acute sequelae in the pulmonary and extra-pulmonary organ systems, in a new study.

Staying true to its long history of committed partnership with healthcare professionals on Continuing Medical Education (CME) and product innovation, ZP Therapeutics made a grand return to face-to-face CME events in celebration of ZP Therapeutics’ illustrious 100-year history as a leading healthcare industry partner. The ZPT Exposition of Experts in Improving Patient Outcomes 2022, themed “Zvolution -Making Healthcare More Accessible”, was held at the Conrad Hotel in Pasay City last 23–24 September 2022 and featured a panel of top-notch speakers whose talks covered a broad range of topics from digital health solutions to Gastroenterology, bone health, immunity as well as critical care in diabetes, and Cardiology. 

Treatment with HTD1801, an ionic salt of berberine and ursodeoxycholic acid with pleiotropic mechanisms of action, appears to substantially improve outcomes in patients with primary sclerosing cholangitis (PSC), according to a study.

To this day, diagnostic delay (DD) remains a problem since the first description of eosinophilic esophagitis (EoE) nearly 30 years ago, reveals a study. Notably, one-third of EoE patients suffer a persistently high DD of at least 10 years.

In patients who had undergone nonelective resection for colonic volvulus, frailty appears to worsen clinical outcomes, according to a recent study. Screening for frailty could help improve risk stratification and guide healthcare decision making.